Literature DB >> 11461918

Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation.

E F Etter1, M Eto, R L Wardle, D L Brautigan, R A Murphy.   

Abstract

We investigated whether myosin light chain phosphatase activity changes during nitric oxide-induced relaxation of contracted intact carotid media and how changes in phosphatase activity mediate this relaxation. We also investigated one mechanism for regulating this phosphatase. Myosin phosphatase activity, myosin light chain phosphorylation, guanosine 3',5'-cyclic monophosphate (cGMP) concentration, and phosphorylation of the inhibitory protein CPI-17 were all assayed in homogenates of one carotid media ring at each time point during nitric oxide-induced relaxation. The application of sodium nitroprusside to histamine-contracted media caused rapid declines in light chain phosphorylation and force. These were temporally correlated with a rapid elevation of cGMP and a large transient increase in myosin phosphatase activity. During the early response to nitroprusside, when force declined, increases in myosin phosphatase activity, concurrent with cGMP-mediated decreases in calcium and myosin light chain kinase activity, could accelerate light chain dephosphorylation. CPI-17 was dephosphorylated upon application of nitroprusside at the same time that myosin phosphatase activity increased, suggesting that the removal of inhibition by phospho-CPI-17 contributed to the increase in myosin phosphatase activity. After 20 min of nitroprusside, myosin phosphatase activity had declined to basal levels, however low force was sustained. Additional light chain phosphorylation-independent mechanisms may be involved in sustaining the relaxation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461918     DOI: 10.1074/jbc.M104737200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  The latch-bridge hypothesis of smooth muscle contraction.

Authors:  Richard A Murphy; Christopher M Rembold
Journal:  Can J Physiol Pharmacol       Date:  2005-10       Impact factor: 2.273

2.  {alpha}-Adrenoceptor constrictor responses and their modulation in slow-twitch and fast-twitch mouse skeletal muscle.

Authors:  David G Lambert; Gail D Thomas
Journal:  J Physiol       Date:  2004-12-23       Impact factor: 5.182

3.  Interactions between the leucine-zipper motif of cGMP-dependent protein kinase and the C-terminal region of the targeting subunit of myosin light chain phosphatase.

Authors:  Eunhee Lee; David B Hayes; Knut Langsetmo; Eric J Sundberg; Terence C Tao
Journal:  J Mol Biol       Date:  2007-08-25       Impact factor: 5.469

4.  Characteristics of the response of the iliac artery to wall shear stress in the anaesthetized pig.

Authors:  R F Kelly; H M Snow
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

5.  Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor.

Authors:  Masumi Eto; Toshio Kitazawa; Fumiko Matsuzawa; Sei-Ichi Aikawa; Jason A Kirkbride; Noriyoshi Isozumi; Yumi Nishimura; David L Brautigan; Shin-Ya Ohki
Journal:  Structure       Date:  2007-12       Impact factor: 5.006

6.  Enhancement of myofilament calcium sensitivity by acute hypoxia in rat distal pulmonary arteries.

Authors:  Letitia Weigand; Larissa A Shimoda; J T Sylvester
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-06-10       Impact factor: 5.464

7.  Intradermal administration of endothelin-1 attenuates endothelium-dependent and -independent cutaneous vasodilation via Rho kinase in young adults.

Authors:  Naoto Fujii; Tatsuro Amano; Lyra Halili; Jeffrey C Louie; Sarah Y Zhang; Brendan D McNeely; Glen P Kenny
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-23       Impact factor: 3.619

Review 8.  Stellate cell contraction: role, regulation, and potential therapeutic target.

Authors:  Russell K Soon; Hal F Yee
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

9.  Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase.

Authors:  Jing Ti Deng; Cindy Sutherland; David L Brautigan; Masumi Eto; Michael P Walsh
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 10.  The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failure.

Authors:  Ozgur Ogut; Frank V Brozovich
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.